Enovis · Health Care
ENOV
$27.07
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995.易诺维公司（EnovisCorporation）是一家专注于骨科的医疗技术公司。该公司由米切尔·雷尔斯和史蒂文·雷尔斯兄弟于1995年以科尔法克斯公司（ColfaxCorporation）之名创立。
Speculative / unprofitable投机／未盈利
Small cap小盘
$2B
Engine stance引擎立场2026-07-20
Neutral — no clear edge中性 — 无明显优势
The daily turn is already in — a low formed @ 20.04 and price is back above the 10-day average. What's missing is the we日线转向已经完成——低点于近期形成 @ 20.04，且价格已重新站上 10 日均线。尚缺的是周线周期的确认，因此这是当下可用的部分信心入场，而非待触发信号：可在此建半仓，或等待周线转向。
Key Statistics关键统计
Price价格
$27.07
18.8% below 52-week high低于52周高点 18.8%
Market Cap市值
$2B
Normal volume正常成交量
Beta贝塔
1.55
Moves about 1.6x the market波动幅度约为市场的 1.6 倍
RSI (14)RSI（14）
60
Elevated偏高
Next Earnings下次财报
2026-08-06 (18d)
Volatility Rank波动率分位
100th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
16.6% of float
Performance价格表现
| Period周期 | ENOV | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +5.1% | -1.5% | Beat the index by 6.6 points跑赢指数 6.6 个百分点 |
| 1 Month近1月 | +29.8% | +0.6% | Beat the index by 29.2 points跑赢指数 29.2 个百分点 |
| 3 Months近3月 | +2.8% | +4.7% | Lagged the index by 1.9 points落后指数 1.9 个百分点 |
| 6 Months近6月 | +12.9% | +7.8% | Beat the index by 5.1 points跑赢指数 5.1 个百分点 |
| Year to date年初至今 | +2.1% | +9.1% | Lagged the index by 7.0 points落后指数 7.0 个百分点 |
| 1 Year近1年 | -12.3% | +19.4% | Lagged the index by 31.7 points落后指数 31.7 个百分点 |
| 3 Years近3年 | -58.5% | +69.4% | Lagged the index by 127.9 points落后指数 127.9 个百分点 |
Technicals技术面
RSI (14)RSI（14）
60
Elevated偏高
vs 50-day相对50日均线
+14.1% vs 50-day avg
vs 200-day相对200日均线
+5.6% vs 200-day avg
Volatility rank波动率分位
100th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$25.88
Don't chase above不追高于
$28.03
Stop止损
$20.04
Cycle turn — awaiting confluence cross周期拐点 — 等待共振交叉确认
Earnings财务业绩
18
days until next report天后公布财报
2026-08-06
Estimates being raised — 10 analysts预期上调 — 10 位分析师
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | ENOV | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 1.04x | 3.52 | 96% |
| P/S市销率 | 0.69x | 3.02 | 89% |
| Earnings yield盈利收益率 | -76.50% | 2.72 | 2% |
| FCF yield自由现金流收益率 | 1.29% | 3.94 | 19% |
| Shareholder yield股东收益率 | 0.23% | 1.89 | 17% |
| EV/EBITDA企业价值/EBITDA | 12.77x | 18.21 | 75% |
| P/FCF市值/自由现金流 | 77.74x | 22.42 | 7% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: -6.0%
Earnings Per Share每股收益
Free Cash Flow自由现金流
Margins利润率
-79.5%Return on Equity股本回报率
-30.9%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | 5.73 |
| Current ratio流动比率 | 2.02 |
Capital Allocation资本配置
| Stock-based comp股权薪酬 | $32.9M |
| Share count change (1y)股数变化（1年） | +2.4% |
Piotroski皮奥特罗斯基 4/9
Altman Z阿尔特曼Z: distress (-0.3)
Watch关注
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Looks cheap vs sector相对行业偏便宜
Cheaper than 70% of its sector on blended multiples综合估值倍数低于行业内 70% 的公司
Beta市场敏感度
1.55×
0.21×3×
Moves about 1.6× the market波动幅度约为市场的 1.6 倍
Financial Health财务健康
4/9
Altman阿尔特曼: distress
Weak financial health财务健康状况偏弱
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
News新闻
1 recent stories — mixed1 篇最新报道，多空参半
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
ENOV reclaimed its 200-day averageENOV 收复200日均线
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: +$0.2M net (2 buyers, 1 sellers)+$0.2M 净值（2 买家，1 卖家）
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Dorsey Asset Management | B | exitexit | 0.0% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 16, 2026
ENOV reclaimed its 200-day averageENOV 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $28.07.收盘重回200日均线 — 经典的多头分界线。$28.07。
Jul 16, 2026
ENOV took relative-strength leadershipENOV 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $28.07.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$28.07。
Jul 15, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 14, 2026
ENOV lost its 200-day averageENOV 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $24.65.收盘跌破200日均线 — 经典的空头分界线。$24.65。
Jul 10, 2026
ENOV reclaimed its 200-day averageENOV 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $25.75.收盘重回200日均线 — 经典的多头分界线。$25.75。
Jul 9, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jul 8, 2026
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS止盈
Jul 7, 2026
ENOV lost its 200-day averageENOV 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $25.52.收盘跌破200日均线 — 经典的空头分界线。$25.52。
Showing last 15 of显示最近15条，共 255 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.04
Value价值
-0.9
Profitability盈利能力
+0.2
Quality质量
+1.3
Investment资本投入
+1.6
Shareholder payout股东回报
-1.0
Low volatility低波动
-1.4
Low market beta低市场敏感度
-0.9
Earnings quality盈利质量
+3.0
Short interest空头兴趣
-2.1
Company Profile公司档案
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995.易诺维公司（EnovisCorporation）是一家专注于骨科的医疗技术公司。该公司由米切尔·雷尔斯和史蒂文·雷尔斯兄弟于1995年以科尔法克斯公司（ColfaxCorporation）之名创立。
Recent News最新动态
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
GlobeNewswire Inc.
2026-07-17
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。